Get the latest Science News and Discoveries
Periostin shows promise to help fight a common form of esophageal cancer - EurekAlert
<p>Esophageal squamous cell carcinoma (ESCC) accounts for around 90% of esophageal cancers, especially in East Asia. New findings in <em>The American Journal of Pathology</em>, published by Elsevier, indicate that periostin, or POSTN, promotes ESCC progression by enhancing cancer and stromal cell migration in cancer-associated fibroblasts (CAFs). Therefore, it may be a novel therapeutic target for treating ESCC.</p>
None
Or read this on Eureka Alert